X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (302) 302
index medicus (298) 298
infantile myofibromatosis (289) 289
male (181) 181
female (161) 161
infant (119) 119
pediatrics (115) 115
infant, newborn (106) 106
surgery (88) 88
diagnosis, differential (85) 85
pathology (81) 81
myofibromatosis - pathology (75) 75
child (74) 74
child, preschool (70) 70
adult (65) 65
immunohistochemistry (61) 61
fibromatosis (56) 56
magnetic resonance imaging (56) 56
myofibromatosis (56) 56
tumors (55) 55
children (53) 53
adolescent (46) 46
myofibroma (44) 44
myofibromatosis - congenital (43) 43
myofibromatosis - diagnosis (41) 41
hemangiopericytoma (39) 39
dermatology (38) 38
myofibroma - pathology (38) 38
oncology (37) 37
diagnosis (36) 36
soft tissue neoplasms - pathology (35) 35
myofibromatosis - surgery (34) 34
radiology, nuclear medicine & medical imaging (34) 34
skin neoplasms - pathology (34) 34
tomography, x-ray computed (34) 34
middle aged (31) 31
infantile fibrosarcoma (30) 30
abridged index medicus (29) 29
biopsy (28) 28
clinical neurology (26) 26
fibrosarcoma (26) 26
follow-up studies (26) 26
chemotherapy (25) 25
dentistry, oral surgery & medicine (25) 25
soft tissue neoplasms - diagnosis (25) 25
dentistry (23) 23
treatment outcome (23) 23
fibroma - pathology (22) 22
infantile myofibroma (22) 22
leiomyoma - pathology (22) 22
myofibroma - diagnosis (22) 22
congenital generalized fibromatosis (21) 21
medicine & public health (21) 21
hemangiopericytoma - pathology (20) 20
ultrasound (20) 20
myofibromatosis - complications (19) 19
bone (18) 18
case report (18) 18
fibrosarcoma - diagnosis (18) 18
fibrosarcoma - pathology (18) 18
myofibroma - surgery (18) 18
myofibromatosis - diagnostic imaging (18) 18
prognosis (18) 18
radiography (18) 18
sarcoma (18) 18
skin neoplasms - diagnosis (18) 18
actins - analysis (17) 17
aged (17) 17
childhood (17) 17
congenital fibrosarcoma (17) 17
fibroma - diagnosis (17) 17
fibromas (17) 17
infants (17) 17
mutation (17) 17
retrospective studies (17) 17
case studies (16) 16
genetics & heredity (16) 16
medicine (16) 16
tumor (16) 16
care and treatment (15) 15
clinicopathological analysis (15) 15
fibrosarcoma - congenital (15) 15
genetic disorders (15) 15
infantile (15) 15
involvement (15) 15
myofibromatosis - genetics (15) 15
spectrum (15) 15
adults (14) 14
biomarkers, tumor - analysis (14) 14
cell biology (14) 14
etv6-ntrk3 gene fusion (14) 14
research (14) 14
solitary (14) 14
receptor, platelet-derived growth factor beta - genetics (13) 13
series (13) 13
soft tissue neoplasms - congenital (13) 13
usage (13) 13
fatal outcome (12) 12
management (12) 12
myopericytoma (12) 12
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (377) 377
French (18) 18
German (9) 9
Spanish (9) 9
Korean (6) 6
Italian (5) 5
Japanese (5) 5
Turkish (2) 2
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Medical Genetics Part A, ISSN 1552-4825, 09/2019, Volume 179, Issue 9, pp. 1895 - 1897
Heterozygous activating mutations in platelet‐derived growth factor receptor B ( PDGFRB ) have been recently identified as a cause of autosomal‐dominant... 
PDGFRB | infantile myofibromatosis | precision oncology | imatinib | GENETICS & HEREDITY | Antimitotic agents | Genetic aspects | Platelet-derived growth factor | Antineoplastic agents | Remission | Imatinib | Mutation
Journal Article
Clinical Nuclear Medicine, ISSN 0363-9762, 08/2019, Volume 44, Issue 8, pp. 676 - 679
ABSTRACTInfantile myofibromatosis, a rare, nonmalignant disease seen almost exclusively in the pediatric population, can involve skin, muscle, soft tissues,... 
infantile myofibromatosis | diagnostic utility | Tc-99m-methylene diphosphonate bone scan | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | whole-body MRI | F-18-FDG PET /CT | CT imaging | Usage | Diagnosis | Pediatric research | Fibromas | Index Medicus
Journal Article
Clinical Cases in Mineral and Bone Metabolism, ISSN 1724-8914, 2017, Volume 14, Issue 2, pp. 241 - 244
Solitary infantile myofibromatosis (IM) of bone is a rare benign osseous tumor of childhood with low rate of recurrence. Well documented within the multicenter... 
Iuac bone | Lytic bone tumor | Infantile myofibromatosfp | infantile myofibromatosis | iliac bone | lytic bone tumor | Case Report
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 12/2018, Volume 179, Issue 6, pp. 1408 - 1409
Journal Article
Journal of Pediatric Hematology/Oncology, ISSN 1077-4114, 07/2015, Volume 37, Issue 5, pp. 402 - 405
Journal Article
International Journal of Molecular Sciences, ISSN 1661-6596, 09/2018, Volume 19, Issue 9, p. 2599
Infantile myofibromatosis represents one of the most common proliferative fibrous tumors of infancy and childhood. More effective treatment is needed for... 
Sunitinib | FR180204 | Erlotinib | Targeted therapy | Platelet-derived growth factor receptor | Protein kinase inhibitors | Infantile myofibromatosis | Receptor tyrosine kinases | U0126 | sunitinib | targeted therapy | ACTIVATION | protein kinase inhibitors | erlotinib | BIOCHEMISTRY & MOLECULAR BIOLOGY | CANCER | CHEMISTRY, MULTIDISCIPLINARY | CHILDREN | receptor tyrosine kinases | SIGNALING PATHWAY | ROLES | RECURRENT | GROWTH | infantile myofibromatosis | platelet-derived growth factor receptor | RESISTANCE | EXPRESSION | Pyrazoles - therapeutic use | Humans | Myofibromatosis - drug therapy | Infant | Male | Receptor, Platelet-Derived Growth Factor beta - genetics | Nitriles - administration & dosage | Pyridazines - administration & dosage | Female | Phosphorylation - drug effects | Sunitinib - administration & dosage | Child | Pyridazines - therapeutic use | Receptor, Platelet-Derived Growth Factor beta - metabolism | Erlotinib Hydrochloride - administration & dosage | Myofibromatosis - congenital | Myofibromatosis - genetics | Protein Kinase Inhibitors - administration & dosage | Pyrazoles - administration & dosage | Sunitinib - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Butadienes - administration & dosage | Cell Line, Tumor | Butadienes - therapeutic use | Cell Proliferation - drug effects | Erlotinib Hydrochloride - therapeutic use | Mutation | Nitriles - therapeutic use | Cell proliferation | Tyrosine | Phosphorylation | Platelet-derived growth factor | Tumor cells | Cyclin-dependent kinases | Extracellular signal-regulated kinase | MAP kinase | Tumor cell lines | Drug resistance | Kinases | Proteins | Inhibitors | Protease inhibitors | Protein-tyrosine kinase receptors | Children | Growth factors | Protein-tyrosine kinase | Tumors | Pediatrics | Oncology | Phosphatase | Signal transduction | Cell growth | Studies | Medical prognosis | Cancer | Index Medicus
Journal Article
Journal Article
Pathology International, ISSN 1320-5463, 08/2015, Volume 65, Issue 8, pp. 432 - 437
Journal Article
European Journal of Medical Genetics, ISSN 1769-7212, 2017, Volume 60, Issue 7, pp. 353 - 358
Journal Article